Related references
Note: Only part of the references are listed.Neuroblastoma Paradigm for Precision Medicine
Meredith S. Irwin et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
Michael J. Burke et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance
Manuel Buscarlet et al.
BLOOD (2014)
BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling
Xiaoran Liu et al.
EUROPEAN JOURNAL OF CANCER (2014)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
Junwei Shi et al.
GENES & DEVELOPMENT (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study
Trent R. Hummel et al.
PEDIATRIC BLOOD & CANCER (2013)
BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
Jin Bai et al.
PLOS ONE (2013)
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
A. Hunter Shain et al.
PLOS ONE (2013)
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
Anastasia Wyce et al.
PLOS ONE (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
Jessica Charlet et al.
BIOCHEMICAL PHARMACOLOGY (2012)
The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer
Octavio A. Romero et al.
EMBO MOLECULAR MEDICINE (2012)
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
Fieke Lamers et al.
EUROPEAN JOURNAL OF CANCER (2012)
BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro
Jin Bai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
KEGG for integration and interpretation of large-scale molecular data sets
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2012)
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Relja Popovic et al.
CANCER DISCOVERY (2012)
Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells
T. Watanabe et al.
BRITISH JOURNAL OF CANCER (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report
Jack M. Su et al.
CLINICAL CANCER RESEARCH (2011)
Targeting Aberrant PI3K/Akt Activation by PI103 Restores Sensitivity to TRAIL-Induced Apoptosis in Neuroblastoma
Daniela Opel et al.
CLINICAL CANCER RESEARCH (2011)
Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions
Patrick G. Buckley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis
A. Bender et al.
ONCOGENE (2011)
BRG1 expression is increased in human cutaneous melanoma
H. Lin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
E. Grau et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids
Hari R. Kumar et al.
PEDIATRIC SURGERY INTERNATIONAL (2008)
Aberrant expression of SWI/SNF catalytic subunits BRGI/BRM is associated with tumor development and increased invasiveness in prostate cancers
Aijing Sun et al.
PROSTATE (2007)
Activation of Akt predicts poor outcome in neuroblastoma
Daniela Opel et al.
CANCER RESEARCH (2007)
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome
Qiwei Yang et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells
M Weber et al.
NATURE GENETICS (2005)
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma
M Alaminos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes
S Kadam et al.
MOLECULAR CELL (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells -: Disappearance of the caspase-activated DNase
VJ Yuste et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of chromatin remodeling factors during neural differentiation
Y Machida et al.
JOURNAL OF BIOCHEMISTRY (2001)
Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas
K Sentani et al.
PATHOBIOLOGY (2001)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
